Høy T, Horsberg E, Nafstad I
Norwegian College of Veterinary Medicine, Department of Pharmacology and Toxicology, Oslo.
Pharmacol Toxicol. 1990 Oct;67(4):307-12. doi: 10.1111/j.1600-0773.1990.tb00835.x.
The disposition of tritium-labelled ivermectin (22,23 di-3H-avermectin, B1a) in Atlantic salmon was studied by whole-body autoradiography, liquid scintillation counting, and thin-layer chromatography. Ivermectin was slowly absorbed, the highest concentrations being found in lipid-containing organs. High concentrations were also found in the central nervous system, indicating that the blood-brain barrier in salmon is poorly developed compared to mammals. The excretion of the drug was very slow. The total amount of radioactivity in blood, muscle, liver and kidney diminished by only 35% from day 4 to day 28 after administration. Excretion was mainly by the biliary route, and enterohepatic circulation of the drug was apparent. The drug was mainly excreted in the unchanged form. Distribution to the central nervous system, and the prolonged excretion period, makes the drug unsuitable for the control of parasitic infestations in salmon.
通过全身放射自显影、液体闪烁计数和薄层色谱法研究了氚标记伊维菌素(22,23 - 二 - 3H - 阿维菌素,B1a)在大西洋鲑鱼体内的分布情况。伊维菌素吸收缓慢,在含脂器官中浓度最高。在中枢神经系统中也发现了高浓度,这表明与哺乳动物相比,鲑鱼的血脑屏障发育不完善。药物排泄非常缓慢。给药后第4天到第28天,血液、肌肉、肝脏和肾脏中的放射性总量仅减少了35%。排泄主要通过胆汁途径,药物的肝肠循环明显。药物主要以未改变的形式排泄。药物分布到中枢神经系统以及排泄期延长,使得该药物不适合用于控制鲑鱼体内的寄生虫感染。